PRECISION BIOSCIENCES INC

For the period ended Sep 30, 2024. Filed Nov 4, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 4, 2024

DTIL$10.60+7.4%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(In thousands, except share and per share amounts)

	For the Three Months Ended September 30,		For the Nine Months Ended September 30,
	2024	2023	2024	2023
Revenue	$576	$13,120	$68,058	$41,689
Operating expenses
Research and development	13,084	15,850	43,652	39,986
General and administrative	8,767	9,633	25,722	30,549
Total operating expenses	21,851	25,483	69,374	70,535
Operating loss	(21,275)	(12,363)	(1,316)	(28,846)
Other income (expense):
Loss from equity method investment	(875)	(1,350)	(112)	(4,060)
Gain (loss) on changes in fair value	571	311	917	(458)
Gain on change in fair value of warrant liability	3,647	—	21,798	—
Interest expense	(256)	(576)	(1,390)	(1,651)
Interest income	1,763	1,870	5,269	5,859
(Loss) gain on disposal of assets	—	(2)	(254)	63
Total other income (expense)	4,850	253	26,228	(247)
(Loss) income from continuing operations	$(16,425)	$(12,110)	$24,912	$(29,093)
Income (loss) from discontinued operations	—	4,031	—	(15,937)
Net (loss) income	$(16,425)	$(8,079)	$24,912	$(45,030)
Net (loss) income per share
Basic	$(2.25)	$(2.10)	$3.87	$(11.90)
Diluted	$(2.25)	$(2.10)	$3.78	$(11.90)
Weighted-average shares of common stock outstanding
Basic	7,287,173	3,838,900	6,441,375	3,784,432
Diluted	7,287,173	3,838,900	6,590,885	3,784,432

Condensed Statements of Changes in

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.